IRADIMED CORPORATION
DE ˙ DB ˙ US46266A1097
76,50 € ↓ -1,50 (-1,92%)
2026-06-03
AKTIENPREIS
SecurityDE:46K / IRADIMED CORPORATION
InstitutionUBS Group AG
Latest Disclosed Ownership14,642 shares
Latest Disclosed Value $ 1,409,439
UBS Group AG reports 13.71% decrease in ownership of 46K / IRADIMED CORPORATION

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 14,642 shares of IRADIMED CORPORATION (DE:46K) valued at $1,193,323 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 16,968 shares of IRADIMED CORPORATION. This represents a change in shares of -13.71% during the quarter. The current value of the position is $1,120,113 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F IRADIMED COM 46266A109 14,642 -2,326 -13.71 1,409 -14.61 0.0000
2026-01-29 2025-12-31 13F IRADIMED COM 46266A109 16,968 -8,465 -33.28 1,651 -8.79 0.0003
2025-11-13 2025-09-30 13F IRADIMED COM 46266A109 25,433 20,242 389.94 1,810 483.55 0.0003
2025-08-14 2025-06-30 13F IRADIMED COM 46266A109 5,191 -3,921 -43.03 310 -35.15 0.0001
2025-05-13 2025-03-31 13F IRADIMED COM 46266A109 9,112 -10,688 -53.98 478 -56.11 0.0001
2025-02-14 2024-12-31 13F IRADIMED COM 46266A109 19,800 13,812 230.66 1,089 261.79 0.0002
2024-11-14 2024-09-30 13F IRADIMED COM 46266A109 5,988 1,260 26.65 301 45.41 0.0001
2024-08-14 2024-06-30 13F IRADIMED COM 46266A109 4,728 -3,747 -44.21 208 -44.35 0.0001
2024-05-13 2024-03-31 13F IRADIMED COM 46266A109 8,475 1,237 17.09 373 8.45 0.0001
2024-02-09 2023-12-31 13F IRADIMED COM 46266A109 7,238 4,349 150.54 344 167.97 0.0001
2023-11-09 2023-09-30 13F IRADIMED COM 46266A109 2,889 -12,149 -80.79 128 -82.15 0.0000
2023-08-11 2023-06-30 13F IRADIMED COM 46266A109 15,038 7,370 96.11 718 138.21 0.0002
2023-05-12 2023-03-31 13F IRADIMED COM 46266A109 7,668 -2,248 -22.67 302 7.50 0.0001
2023-02-08 2022-12-31 13F IRADIMED COM 46266A109 9,916 9,125 1,153.60 281 1,066.67 0.0001
2022-11-10 2022-09-30 13F IRADIMED COM 46266A109 791 -602 -43.22 24 -48.94 0.0000
2022-08-10 2022-06-30 13F IRADIMED COM 46266A109 1,393 -1,229 -46.87 47 -59.83 0.0000
2022-05-16 2022-03-31 13F IRADIMED COM 46266A109 2,622 174 7.11 117 3.54 0.0000
2022-02-14 2021-12-31 13F IRADIMED COM 46266A109 2,448 2,448 113 0.0000
2021-11-15 2021-09-30 13F IRADIMED COM 46266A109 0 -3 -100.00 0 0.0000
2021-08-13 2021-06-30 13F IRADIMED COM 46266A109 3 -1,677 -99.82 0 -100.00
2021-05-12 2021-03-31 13F IRADIMED COM 46266A109 1,680 536 46.85 43 65.38 0.0000
2021-02-11 2020-12-31 13F IRADIMED COM 46266A109 1,144 -212 -15.63 26 -10.34 0.0000
2020-11-12 2020-09-30 13F IRADIMED COM 46266A109 1,356 -1,184 -46.61 29 -50.85 0.0000
2020-07-31 2020-06-30 13F IRADIMED COM 46266A109 2,540 -2,104 -45.31 59 -40.40 0.0000
2020-05-01 2020-03-31 13F IRADIMED COM 46266A109 4,644 -1,640 -26.10 99 -32.65 0.0000
2020-02-14 2019-12-31 13F IRADIMED COM 46266A109 6,284 1,427 29.38 147 44.12 0.0001
2019-11-14 2019-09-30 13F IRADIMED COM 46266A109 4,857 606 14.26 102 17.24 0.0000
2019-08-14 2019-06-30 13F IRADIMED COM 46266A109 4,251 2,735 180.41 87 102.33 0.0000
2019-05-14 2019-03-31 13F IRADIMED COM 46266A109 1,516 -39 -2.51 43 13.16 0.0000
2019-02-14 2018-12-31 13F IRADIMED COM 46266A109 1,555 -313 -16.76 38 -44.93 0.0000
2018-11-14 2018-09-30 13F IRADIMED COM 46266A109 1,868 -157 -7.75 69 64.29 0.0000
2018-08-14 2018-06-30 13F IRADIMED COM 46266A109 2,025 256 14.47 42 68.00 0.0000
2018-05-15 2018-03-31 13F IRADIMED COM 46266A109 1,769 28 1.61 25 -3.85 0.0000
2018-02-14 2017-12-31 13F IRADIMED COM 46266A109 1,741 1,741 26 0.0000
2017-11-14 2017-09-30 13F IRADIMED COM 46266A109 0 -4,130 -100.00 0 -100.00
2017-11-14 2017-06-30 13F/A-1 IRADIMED COM 46266A109 4,130 2,564 163.73 35 150.00 0.0000
2017-08-14 2017-06-30 13F IRADIMED COM 46266A109 4,130 2,564 35
2017-11-14 2017-03-31 13F/A-1 IRADIMED COM 46266A109 1,566 -798 -33.76 14 -46.15 0.0000
2017-05-12 2017-03-31 13F IRADIMED COM 46266A109 1,566 -798 14
2017-02-14 2016-12-31 13F IRADIMED COM 46266A109 2,364 323 15.83 26 -25.71 0.0000
2016-11-14 2016-09-30 13F IRADIMED COM 46266A109 2,041 1,628 394.19 35 288.89 0.0000
2016-08-12 2016-06-30 13F IRADIMED COM 46266A109 413 413 0.00 9 0.0000
2016-05-12 2016-03-31 13F IRADIMED COM 46266A109 0 -24,002 -100.00 0 -100.00
2016-02-16 2015-12-31 13F IRADIMED COM 46266A109 24,002 24,002 0.00 673 0.0004
2015-08-14 2015-06-30 13F IRADIMED COM 46266A109 0 -1,013 -100.00 0 -100.00
2015-05-14 2015-03-31 13F IRADIMED COM 46266A109 1,013 1,013 15 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.